 Matthew Zuckerman
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical | 2 | 2021 | 260 | 1.040 |
Why?
| | Drug Overdose | 4 | 2024 | 344 | 1.020 |
Why?
| | Poisoning | 2 | 2018 | 116 | 0.990 |
Why?
| | Health Occupations | 1 | 2024 | 33 | 0.900 |
Why?
| | Xylazine | 1 | 2024 | 14 | 0.880 |
Why?
| | Schools, Medical | 1 | 2023 | 146 | 0.780 |
Why?
| | Faculty | 1 | 2023 | 144 | 0.770 |
Why?
| | Teaching | 1 | 2024 | 226 | 0.770 |
Why?
| | Manipulation, Spinal | 1 | 2022 | 8 | 0.760 |
Why?
| | Opioid-Related Disorders | 2 | 2020 | 504 | 0.730 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2022 | 58 | 0.700 |
Why?
| | Intracranial Hypotension | 1 | 2022 | 41 | 0.700 |
Why?
| | Headache | 1 | 2022 | 151 | 0.690 |
Why?
| | Toxicology | 1 | 2021 | 46 | 0.680 |
Why?
| | Urticaria | 1 | 2020 | 38 | 0.660 |
Why?
| | Buprenorphine | 2 | 2020 | 167 | 0.650 |
Why?
| | Textbooks as Topic | 1 | 2019 | 3 | 0.620 |
Why?
| | Anaphylaxis | 1 | 2020 | 105 | 0.620 |
Why?
| | Fentanyl | 2 | 2024 | 94 | 0.610 |
Why?
| | Ethylene Glycol | 1 | 2018 | 16 | 0.580 |
Why?
| | Video Recording | 1 | 2019 | 181 | 0.570 |
Why?
| | Narcotic Antagonists | 3 | 2020 | 178 | 0.570 |
Why?
| | Faculty, Medical | 1 | 2021 | 282 | 0.560 |
Why?
| | Analgesics, Opioid | 4 | 2024 | 991 | 0.550 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 306 | 0.540 |
Why?
| | Altruism | 1 | 2016 | 27 | 0.510 |
Why?
| | Lactic Acid | 1 | 2018 | 306 | 0.510 |
Why?
| | Emergency Medicine | 1 | 2019 | 224 | 0.500 |
Why?
| | Acetaminophen | 1 | 2019 | 268 | 0.500 |
Why?
| | Pharmacokinetics | 1 | 2015 | 29 | 0.490 |
Why?
| | Attitude of Health Personnel | 2 | 2020 | 1157 | 0.460 |
Why?
| | Pigmentation Disorders | 1 | 2014 | 9 | 0.450 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2014 | 20 | 0.450 |
Why?
| | Apnea | 1 | 2014 | 22 | 0.440 |
Why?
| | Curriculum | 1 | 2021 | 979 | 0.430 |
Why?
| | Living Donors | 1 | 2016 | 295 | 0.430 |
Why?
| | Ferric Compounds | 1 | 2014 | 55 | 0.430 |
Why?
| | Naloxone | 1 | 2014 | 120 | 0.410 |
Why?
| | Minocycline | 1 | 2012 | 27 | 0.390 |
Why?
| | Physicians | 1 | 2020 | 897 | 0.370 |
Why?
| | Skin Diseases | 1 | 2012 | 148 | 0.340 |
Why?
| | Viperidae | 1 | 2010 | 7 | 0.340 |
Why?
| | Kidney Transplantation | 1 | 2016 | 700 | 0.320 |
Why?
| | Emergency Service, Hospital | 6 | 2022 | 2050 | 0.280 |
Why?
| | Cannabinoids | 2 | 2020 | 161 | 0.270 |
Why?
| | Adult | 10 | 2022 | 37616 | 0.260 |
Why?
| | Marijuana Abuse | 2 | 2020 | 233 | 0.260 |
Why?
| | Humans | 21 | 2024 | 136783 | 0.250 |
Why?
| | Videotape Recording | 1 | 2023 | 35 | 0.210 |
Why?
| | Capsaicin | 2 | 2020 | 26 | 0.200 |
Why?
| | Male | 10 | 2022 | 67361 | 0.190 |
Why?
| | Writing | 1 | 2023 | 94 | 0.190 |
Why?
| | Educational Status | 2 | 2023 | 482 | 0.190 |
Why?
| | Vomiting | 2 | 2020 | 129 | 0.190 |
Why?
| | Hypnotics and Sedatives | 1 | 2024 | 199 | 0.190 |
Why?
| | Obesity | 1 | 2015 | 2975 | 0.190 |
Why?
| | Myelography | 1 | 2022 | 33 | 0.190 |
Why?
| | Opiate Substitution Treatment | 2 | 2020 | 147 | 0.180 |
Why?
| | Histamine Antagonists | 1 | 2020 | 21 | 0.170 |
Why?
| | Learning | 1 | 2024 | 414 | 0.170 |
Why?
| | Epinephrine | 1 | 2020 | 139 | 0.160 |
Why?
| | Certification | 1 | 2020 | 103 | 0.160 |
Why?
| | Patient Handoff | 1 | 2020 | 33 | 0.160 |
Why?
| | Cold Temperature | 1 | 2020 | 177 | 0.160 |
Why?
| | Antiemetics | 1 | 2019 | 43 | 0.150 |
Why?
| | Social Work | 1 | 2020 | 84 | 0.150 |
Why?
| | Malingering | 1 | 2018 | 28 | 0.140 |
Why?
| | HIV Infections | 1 | 2012 | 2812 | 0.140 |
Why?
| | Unrelated Donors | 1 | 2016 | 39 | 0.130 |
Why?
| | Educational Measurement | 1 | 2019 | 280 | 0.130 |
Why?
| | Marijuana Smoking | 1 | 2019 | 250 | 0.120 |
Why?
| | Absorption, Physiological | 1 | 2015 | 4 | 0.120 |
Why?
| | Biotransformation | 1 | 2015 | 66 | 0.120 |
Why?
| | Miosis | 1 | 2014 | 3 | 0.110 |
Why?
| | Respiratory Rate | 1 | 2014 | 20 | 0.110 |
Why?
| | Administration, Intranasal | 1 | 2014 | 90 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2020 | 777 | 0.110 |
Why?
| | Biological Availability | 1 | 2014 | 147 | 0.110 |
Why?
| | Middle Aged | 4 | 2021 | 33200 | 0.110 |
Why?
| | Antidotes | 1 | 2015 | 143 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 408 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2677 | 0.100 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 1483 | 0.100 |
Why?
| | Acne Vulgaris | 1 | 2012 | 28 | 0.100 |
Why?
| | Colorado | 2 | 2019 | 4491 | 0.090 |
Why?
| | Female | 5 | 2021 | 72840 | 0.090 |
Why?
| | Physician-Patient Relations | 1 | 2016 | 544 | 0.090 |
Why?
| | Energy Drinks | 1 | 2011 | 4 | 0.090 |
Why?
| | Young Adult | 3 | 2019 | 13126 | 0.090 |
Why?
| | Animals | 3 | 2024 | 36768 | 0.090 |
Why?
| | Drug Utilization | 1 | 2012 | 170 | 0.090 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2011 | 94 | 0.090 |
Why?
| | Heart Rate | 1 | 2014 | 823 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3566 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5417 | 0.080 |
Why?
| | Risk-Taking | 1 | 2012 | 348 | 0.080 |
Why?
| | Prevalence | 1 | 2015 | 2712 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 2014 | 548 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2012 | 485 | 0.070 |
Why?
| | Seizures | 1 | 2011 | 430 | 0.070 |
Why?
| | Blood Pressure | 1 | 2014 | 1772 | 0.070 |
Why?
| | Prognosis | 1 | 2015 | 4018 | 0.070 |
Why?
| | Education, Medical, Graduate | 1 | 2011 | 481 | 0.060 |
Why?
| | Parkinson Disease | 1 | 2012 | 491 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5749 | 0.060 |
Why?
| | Risk Assessment | 1 | 2015 | 3429 | 0.060 |
Why?
| | Association | 1 | 2005 | 12 | 0.060 |
Why?
| | Length of Stay | 2 | 2020 | 1208 | 0.050 |
Why?
| | Mental Recall | 1 | 2005 | 201 | 0.050 |
Why?
| | Taste | 1 | 2005 | 229 | 0.050 |
Why?
| | United States | 1 | 2020 | 14660 | 0.050 |
Why?
| | Language | 1 | 2005 | 296 | 0.050 |
Why?
| | Risk Factors | 1 | 2015 | 10331 | 0.040 |
Why?
| | Internship and Residency | 1 | 2011 | 1131 | 0.040 |
Why?
| | Adolescent | 3 | 2019 | 21463 | 0.040 |
Why?
| | Wisconsin | 1 | 2020 | 101 | 0.040 |
Why?
| | Community Health Workers | 1 | 2020 | 61 | 0.040 |
Why?
| | Administration, Topical | 1 | 2019 | 148 | 0.040 |
Why?
| | Nausea | 1 | 2019 | 111 | 0.040 |
Why?
| | Syndrome | 1 | 2019 | 357 | 0.040 |
Why?
| | Abdominal Pain | 1 | 2019 | 145 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 10764 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2020 | 278 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2020 | 15564 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2011 | 132 | 0.020 |
Why?
| | Caffeine | 1 | 2011 | 68 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7569 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2011 | 1568 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 1024 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2011 | 5115 | 0.010 |
Why?
| | Child Development | 1 | 2005 | 471 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6792 | 0.010 |
Why?
| | Aged | 1 | 2019 | 23729 | 0.010 |
Why?
| | Child, Preschool | 1 | 2005 | 11069 | 0.010 |
Why?
| | Child | 1 | 2005 | 21968 | 0.000 |
Why?
|
|
Zuckerman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|